New Data Shows Teladoc Health’s Integrated Chronic Care Solutions Deliver Improved Health Outcomes
July 15, 2022 09:00 ET
|
Teladoc Health, Inc.
PURCHASE, NY, July 15, 2022 (GLOBE NEWSWIRE) -- Teladoc Health (NYSE: TDOC), the global leader in whole-person virtual care, today released new findings showing that managing multiple chronic...
Global Renal Denervation (RDN) Market is valued at $140 Million (2022) and is growing at a lucrative CAGR of 40%
June 06, 2022 09:45 ET
|
Medi-Tech Insights
Brussels, Belgium, June 06, 2022 (GLOBE NEWSWIRE) -- Description: Resistant hypertension is a blood pressure that remains elevated above target levels despite use of anti-hypertensive...
The First PHantasticals Come to Life to Raise Awareness of Pulmonary Hypertension
May 05, 2022 05:00 ET
|
Ferrer
BARCELONA, Spain, May 05, 2022 (GLOBE NEWSWIRE) -- Coinciding with World Pulmonary Hypertension (PH) Day, which is celebrated every May 5, Ferrer and the European Pulmonary Hypertension Association...
Growth: Global Urinalysis Market Estimated to Surpass $4,776.9 by 2028 and Grow at 6.3% CAGR in the 2021 to 2028 Timeframe [170-Pages] | Confirmed by Research Dive
March 29, 2022 09:01 ET
|
Research Dive
New York, USA, March 29, 2022 (GLOBE NEWSWIRE) -- According to the report published by Research Dive, the global urinalysis market is anticipated to gather a revenue of $4,776.9 million by 2028 and...
Direct Relief, BD, NAFC Announce Free and Charitable Clinic Grant Winners
January 26, 2022 10:28 ET
|
National Association of Free & Charitable Clinics
Alexandria, VA, Jan. 26, 2022 (GLOBE NEWSWIRE) -- In their continued effort to help vulnerable populations access health care services that address chronic disease, Direct Relief, BD (Becton,...
Casana Closes $30 Million Series B Funding to Accelerate Development of Novel Effortless Home Health Monitoring
January 21, 2022 12:15 ET
|
Casana Care, Inc.
ROCHESTER, N.Y., Jan. 21, 2022 (GLOBE NEWSWIRE) -- Casana, a healthcare technology firm that is reinventing in-home health monitoring, announced today that it has raised $30 million in Series B...
Cardiometabolic Diseases Market Size ($121,804.49Mn by 2028) Lead by Cardiovascular Disease (3.9% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 29, 2021 09:54 ET
|
The Insight Partners
New York, Oct. 29, 2021 (GLOBE NEWSWIRE) -- Cardiometabolic Diseases Market: Key InsightsAccording to our new research study on Cardiometabolic Diseases Market Size and Forecast to 2028 - COVID-19...
Embolization Agents Market Size ($4,525.75Mn by 2028) Lead by Coil Segment (7.6% CAGR) Impact of Coronavirus Outbreak and Global Analysis & Forecast by TheInsightPartners.com
October 22, 2021 08:22 ET
|
The Insight Partners
New York, Oct. 22, 2021 (GLOBE NEWSWIRE) -- The new research study on the Embolization Agents Market Size and Forecast to 2028 by Product (Coils, Plugs, Beads/Particles, Detachable Balloons, Glue,...
Worldwide Diltiazem Industry to 2028 - Increase in Cardiovascular Disease Incidence is Driving Growth
October 21, 2021 06:58 ET
|
Research and Markets
Dublin, Oct. 21, 2021 (GLOBE NEWSWIRE) -- The "Global Diltiazem Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Capsules, Injection, and Tablets); Application (Angina,...
Lexaria Bioscience Corp. (NASDAQ: LEXX) Emerging as Leader in Pursuit of More-Effective Hypertension Treatment
September 16, 2021 08:30 ET
|
Lexaria Bioscience Corp.
NEW YORK, Sept. 16, 2021 (GLOBE NEWSWIRE) -- NetworkNewsAudio – Lexaria Bioscience Corp. (NASDAQ: LEXX) announces the availability of a broadcast titled, “Hypertension: The Silent Killer Making Loud...